Jeff Pavell serves as Executive at Hoth Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jeff Pavell has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 13, 2022 involved receiving (via award) 5,075 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 13, 2022 | HOTH | $0 | Award | 5,075 | $N/A | Discretionary |
Jeff Pavell currently holds 5,075 shares of Hoth Therapeutics, Inc. (HOTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeff Pavell has been a net neutral trader of HOTH stock. They have purchased $0 and sold $0 worth of shares.
Jeff Pavell's most recent insider trade was on Dec 13, 2022, when they sold 5,075 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted